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Thyroid hormone (T3) influences a variety of physiological processes, including cell growth and metabolism in mammals.
T3 has been shown to be a powerful inducer of cardiomyocyte hypertrophy [1] and cardiac hypertrophy [2, 3] . Indeed, thyroid hormone enhances protein synthesis in the heart [4, 5] . T3 has strong mitogenic effect and can induce cell proliferation in rats [6, 7] [8, 9] . There are two major TR isoforms encoded on separate genes, designated as TR␣ and TR␤, encoded on human chromosomes 17 and 3, respectively [10] . Alternative splicing of the initial RNA transcript of TR␣ gene generates two mature mRNA that encode two proteins: TR␣1 and c-erbA␣2 (TR␣2). The latter cannot bind T3 because it contains a 122-amino acid caboxy terminus that replaces a region in TR␣1, which is critical for thyroid hormone binding [11] . There are also two TRs derived from the TR␤ gene. This gene contains two promoter regions each of which is vital for the transcription of an mRNA coding for a distinctive protein [12] . TR␤1 mRNA is highly expressed in liver, whereas TR␤2 mRNA is highly expressed in the anterior pituitary [13] . In present study, we demonstrated that TR␣1 expressed in rat aorta smooth muscle (RASM) cells. The first objective of this study was to determine if T3 induces RASM cell proliferation in a TR␣1-dependent manner. We hypothesize that T3 induces RASM cell proliferation via TR␣1.
. It is not known, however, if T3 induces artery smooth muscle cell (SMC) proliferation. The actions of thyroid hormone are primarily mediated by thyroid hormone receptors (TRs) (genomic effect), which belong to the family of nuclear hormone receptors containing a DNA-binding and a ligand-binding domain
NOX1, a novel homologue of gp91, is highly expressed in colon epithelium [14] [15] [16] . It is also expressed in a variety of other cell types, such as endothelial cells [17, 18] and vascular smooth muscle cells (VSMC) [19] [20] [21] . Platelet-derived growth factor (PDGF), prostaglandin F2␣, angiotensin II, phorbol ester and ATF-1 induce NOX1 expression in VSMC [14, [22] [23] [24] . NOX1 was implicated in the pathogenesis of atherosclerosis, hypertension and restenosis after angioplasty because it mediates the proliferation and hypertrophy of VSMC [25] . Reactive oxygen species (ROS), generated by NADPH oxidases, are implicated in mitogenic signalling in cancer [26] [27] [28] . ROS generation is generally a cascade of reactions that starts with the production of superoxide. Superoxide production was decreased significantly in NOX1-deficient mice [29] . ROS Western blot analysis of NOX1, NOX2, SM ␣-actin, proliferating cellular nuclear antigen (PCNA) and TR␣1
The procedure for Western blotting was described in our previous studies [30, 31] 
RNA isolation and semi-quantitative RT-PCR of NOX1
Semi-quantitative RT-PCR was performed as described in our previous study [32] . Briefly 
Results
TR␣1 and NOX1 co-localized in RASM cells
To determine the association of TR␣1 and NOX1 in RASM cells, we evaluated the sub-cellular localization of TR␣1 and NOX1. TR␣1 was predominately localized adjacent to the nuclear periphery (Fig. 1A) . NOX1 was mainly localized around the nucleus and some were found in plasma membrane and submembrane-vesicle-like structure (Fig. 1B) . Clearly, TR␣1 and NOX1 co-localized around the nucleus (Fig. 1D ). (Fig. 3A and B) . T3 did not change RASM cell size. RASM cell proliferation was further evaluated by Western blot analysis of PCNA and SM ␣-actin. T3 increased PCNA and SM ␣-actin expression significantly (Fig. 3C-E) . T3 did not alter ␤-actin (internal control) expression.
Thyroid hormone (T3) selectively increased NOX1 expression
T3 increased RASM cell proliferation
After RASM cells were treated with T3 for 40 hrs, the cytokinesis was evaluated by counting the number of dividing cells. T3 significantly increased the number of cells undergoing cytokinesis
RNAi silence of TR␣1 blocked T3-induced ROS production
The role of TR␣1 in mediating T3-induced ROS generation was evaluated by RNAi silence of TR␣1. TR␣1-siRNA significantly decreased intracellular ROS production compared with cells treated with Sc-siRNA (Scrambled-siRNA) (Fig. 4A and B (Fig. 4C and D) , suggesting complete inhibition of TR␣1. In contrast, ␤-actin was not altered by TR␣1-siRNA or T3 (Fig. 4D) .
RNAi silence of TR␣1 abolished T3-induced increases in NOX1, SM ␣-actin and PCNA expression TR␣1-siRNA significantly attenuated NOX1 expression compared with cells treated with Sc-siRNA (Fig. 5A and D (Fig. 5B-D) . These data suggest that TR␣1 lies in the upstream of NOX1 in TR␣1-NOX1 pathway. TR␣1-siRNA did not affect ␤-actin expression.
RNAi silence of NOX1 abolished T3-induced ROS production
To determine the role of NOX1 in T3-induced ROS generation, the effect of NOX1-shRNA on T3-induced intracellular ROS production was evaluated by using H2DCF staining. NOX1-shRNA significantly decreased intracellular ROS level compared with cells treated with Sc-shRNA ( Fig. 6A and B) . Notably, NOX1-shRAN abolished T3-induced intracellular ROS production. NOX1-shRNA significantly decreased NOX1 protein expression compared with cells treated with Sc-shRNA (Fig. 6C and D) , indicating effective silence of NOX1. NOX1-shRNA also blocked T3-induced up-regulation of NOX1.
RNAi silence of NOX1 abolished T3-induced increases in SM ␣-actin, PCNA and NOX1 expression but did not alter TR␣1 expression
RNAi silence of NOX1 by NOX1-shRNA did not affect TR␣1 expression and the T3-induced increase in TR␣1 expression in
Fig. 2 Thyroid hormone (T3) up-regulated NOX1 expression in RASM cells. RASM cells (1 ϫ 10 6 /dish) were seeded in DMEM medium containing 10% foetal bovine serum, 100 U of penicillin and 100 g of streptomycin at 37ЊC, 5% CO2 for 24 hrs. The cells were then incubated with DMEM containing thyroid hormone (7.5 nM), 2% foetal bovine serum, 100 U of penicillin and 100 g of streptomycin for additional 40 hrs. Following incubation, RASM cells were harvested for Western blot and RT-PCR. (A and B) NOX1 protein expression level. (C and D) NOX1 mRNA expression. (E) NOX2 protein expression. The results were expressed as the total counts of CNT (density [CNT*mm 2 ] times area [mm 2 ]). Equal amounts of protein loading were confirmed with ␤-actin. The error bars represent the standard errors from three experiments (A, C and E). ***P Ͻ 0.001, compared with untreated cells.
RASM cells (Fig. 7A and D (Fig. 7D ). (Fig. 8A and B T3-induced ROS production was solely mediated by NOX1 since RNAi silence of NOX1 completely abolished T3-induced ROS production. Indeed, T3 did not affect expression of NOX2 (gp91phox), a membrane-bound NADPH oxidase [35] , probably because T3 mainly binds to its nuclear receptor (TR␣1).
RNAi silence of NOX1 abolished the T3-induced increase in PCNA-positive cells
(A) The cells undergoing cytokinesis were counted under the microscope with 20ϫ objective. (B) Arrows indicated cytokinesis (dividing cells); 1, un-treated cells; 2, T3-treated cells. RASM cells with the same treatment were harvested with whole cell lysis buffer for measuring PCNA (C) and ␣-actin (D) using Western blot. ␤-actin was used as an internal control. (E) Representative Western blots of PCNA (~29 kD) and ␣-actin (~42 kD). The error bars represent the standard error from three experiments (A, C and D
It is noted that T3 also up-regulated TR␣1 expression, which apparently challenges the traditional receptor theory that an increase in ligand down-regulates its receptors. The mechanism by which this occurs needs to be further investigated but it is not due to T3-induced activation of NOX1 or subsequent ROS production because RNAi inhibition of NOX1 did not affect T3-induced up-regulation of TR␣1 expression.
PCNA is involved in DNA replication and is necessary for adequate leading strand synthesis, acting as the auxiliary protein of DNA polymerase ␦ [36, 37] . The staining pattern of the S-phaserelated PCNA resembles the topographical patterns of DNA replication sites [38] . Thus, PCNA has been used as a marker for cells [42] . Thyroid hormone may suppress DNA synthesis and cell proliferation in the adult VSMC (primary culture) [43, 44] . Treatment of human papillary and follicular thyroid cancer cells with T3 resulted in enhanced cell proliferation, measured by PCNA [45] . Additional experiments showed that DNA synthesis was induced as early as 2 days after T3 treatment [46] . The present study revealed that T3 selectively up-regulated NOX1, the key factor that mediated T3-induced SMC proliferation in [47] . One study in VSMC suggests an endoplasmic reticulum (ER) pattern [48] . Another report describes that NOX1 is co-localized with caveolin in punctate patches on the surface and along cellular margins [49] . In contrast to neutrophils, VSMCs can use NOX1 rather than NOX2 (gp91phox) as a catalytic centre in the p22phox-based oxidase at or near the plasma membrane and submembrane vesicular structures in unstimulated cells [50] . NOX1 mediates NADPH-dependent production of ROS in RASM cells stimulated with angiotensin II and PDGF [23] 
